Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 078 306.6 |
96 | EP file number | EAKZ | 14 79 1646.4 |
86 | WO file number | WAKZ | PCT/US2014/036590 |
97 | EP publication number | EPN | 2991706 |
87 | WO publication number | WPN | 2014179698 |
54 | Designation/title | TI | VORRICHTUNG UND VERFAHREN ZUR OKULAREN INJEKTION |
51 | IPC main class | ICM (ICMV) | A61M 5/48 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61M 5/46 (2006.01), A61M 37/00 (2006.01), A61J 1/20 (2006.01), A61M 5/20 (2006.01), A61M 5/315 (2006.01), A61F 9/00 (2006.01) |
22 | DE application date | DAT | May 2, 2014 |
96 | EP application date | EAT | May 2, 2014 |
86 | WO application date | WAT | May 2, 2014 |
43 | Date of first publication | OT | Nov 6, 2014 |
| Date of publication of grant | PET | Jun 23, 2021 |
71/73 | Applicant/owner | INH | Clearside Biomedical, Inc., Alpharetta, GA, US |
72 | Inventor | IN | ANDINO, Rafael Victor, Grayson, Georgia 30017, US; ZARNITSYN, Vladimir, Atlanta, Georgia 30341, US; BROOKS, Christopher John, Huntington, New York 11743, US; YOO, Jesse, Snellville, Georgia 30078, US; KAHUTE, Trent John, Atlanta, Georgia 30319, US; ARSENAULT, Justin William, Atlanta, Georgia 30316, US; TRETTIN, David Jackson, Atlanta, Georgia 30307, US; BAUER, Andrew Kent, Atlanta, Georgia 30306, US; LEWIS, Stephanie Elaine, Atlanta, Georgia 30306, US |
| Address for service | | Clearside Biomedical, Inc., Alpharetta, GA 30005, US |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201461944214 P Feb 25, 2014
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361827371 P May 24, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201461953147 P Mar 14, 2014
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361819052 P May 3, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361819048 P May 3, 2013
|
| Due date | FT FG | May 31, 2025 Annual fee for the 12th year
Patent fees |
| Patent division in charge | | 41 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document: EP000002991706 Searchable text:
EP000002991706 Original document:
EP000002991706B1 Searchable text:
EP000002991706B1 Original document:
WO002014179698 Searchable text:
WO002014179698 |
43 | Date of first publication | EVT | Nov 6, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Apr 21, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 19, 2024 (Show all update days)(Hide all update days)- Sep 19, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 20.05.2024: changed
- Aug 29, 2024
- Procedures: Opposition procedure, Patent maintained in full by EPO, 20.05.2024: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 20.05.2024: new
- Jun 8, 2024; May 29, 2024; May 9, 2024; Apr 25, 2024; Apr 11, 2024; Jul 8, 2022; May 28, 2022; May 4, 2022; Apr 7, 2022; Jul 15, 2021; Jun 3, 2021; Dec 10, 2020; Jun 28, 2018; Dec 28, 2017
- Historical data not available for this/these date(s)
- Apr 21, 2016
- Date of the first transfer into DPMAregister
|